FacebookInstagramTwitterContact

 

Blood Donation Campaign           >>           Miscellaneous Offences Act           >>           Panel Discussion           >>           BICAM 2024 Opening           >>           Closing Ceremony of UBD-AUN Summer Camp 2024           >>           Visit by AIPA CAUCUS Delegation           >>           Closing of 15th AIPA CAUCUS Meeting           >>           15th AIPA CAUCUS           >>           Series of Visits to Hotels Accommodation           >>           Haj Review Course           >>          

 

SHARE THIS ARTICLE




REACH US


GENERAL INQUIRY

[email protected]

 

ADVERTISING

[email protected]

 

PRESS RELEASE

[email protected]

 

HOTLINE

+673 222-0178 [Office Hour]

+673 223-6740 [Fax]

 



Upcoming Events





Prayer Times


The prayer times for Brunei-Muara and Temburong districts. For Tutong add 1 minute and for Belait add 3 minutes.


Imsak

: 05:01 AM

Subuh

: 05:11 AM

Syuruk

: 06:29 AM

Doha

: 06:51 AM

Zohor

: 12:32 PM

Asar

: 03:44 PM

Maghrib

: 06:32 PM

Isyak

: 07:42 PM

 



The Business Directory


 

 



Xinhua News Agency


  Home > Xinhua News Agency


Commentary: Safety Top Priority For COVID-19 Vaccine Development


 


 September 25th, 2020  |  15:32 PM  |   185 views

BEIJING

 

As scientists around the world are racing against time to develop COVID-19 vaccines, vaccine safety should be seen as a priority in research and development.

 

China values safety in the process of vaccine development. Chinese researchers have tested vaccines on various animals before clinical trials. They've also got promising results on the vaccines' safety and efficacy in phase-1 and phase-2 clinical trials and published the results in international journals, sharing information with the international community in an open, transparent, and responsible manner.

 

As phase-3 clinical trials are essential to evaluate the safety and efficacy of vaccines, China is ramping up efforts and pushing for international cooperation for its four vaccines that have entered phase-3 clinical trials. The phase-3 clinical trials in several countries in the Middle East, South America, and Southeast Asia are progressing smoothly.

 

The development of COVID-19 vaccines is a rigorous and complex procedure, facing uncertainties.

 

On Sept. 8, AstraZeneca and the University of Oxford temporarily halted worldwide phase-3 clinical trials of their vaccine, following an unexplained illness in one trial participant in Britain. Some of the clinical trials resumed after a safety investigation.

 

The event drew concern on possible side effects and acted as a reminder of vaccine safety. However, some western politicians have turned a deaf ear to the wake-up call and kept politicizing the vaccine development in disregard of safety.

 

They made bold assertions and rolled out a set timetable for the application of vaccines to gain political advantages. They even put pressure on health experts, trying to distribute a vaccine before it is ready for use.

 

Instead of politics, science should play the leading role in determining whether or when a vaccine should be approved. Shortcuts in vaccine development and compromises in safety standards in favor of political purposes will undermine the public's trust in vaccines.

 

The development of COVID-19 vaccines should not yield to political pressure. It should stick to scientific procedures and guarantee safety, protecting public health and leading to early victory over the pandemic.

 


 

Source:
courtesy of XINHUA NEWS AGENCY

by XINHUA NEWS AGENCY

 

If you have any stories or news that you would like to share with the global online community, please feel free to share it with us by contacting us directly at [email protected]

 

Related News


Lahad Datu Murder: Remand Of 13 Students Extende

 2024-03-30 07:57:54

BTS' Jin To Hug 1,000 Fans As He Returns From Army

 2024-06-13 00:23:13

Airport Bosses Criticise Sudden Liquids U-Turn

 2024-06-13 01:04:57